Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma

Nervtex AI Device Approved in China to Diagnose Parkinson’s

CARsgen to Test Claudin18.2 mAb with Roche’s PD-L1 for Gastric Cancer

Help Therapeutics to Start Trial of Universal Cell Therapy for Heart Failure

HuidaGene’s CRISPR Therapy Approved to Start US Trial for Inherited Retinal Disease

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China